Risedronic acid: Difference between revisions
CSV import |
CSV import |
||
| Line 59: | Line 59: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Risedronate.svg|Risedronic acid | |||
</gallery> | |||
Latest revision as of 01:18, 20 February 2025
Risedronic acid (also known as risedronate) is a type of medication used to treat and prevent osteoporosis, Paget's disease, and bone disorders. It belongs to a class of drugs known as bisphosphonates.
Overview[edit]
Risedronic acid works by slowing bone loss to help maintain strong bones and reduce the risk of fractures. It is usually taken orally, and is available in both tablet and delayed-release capsule form.
Uses[edit]
Risedronic acid is primarily used to treat:
- Osteoporosis in postmenopausal women
- To increase bone mass in men with osteoporosis
- Paget's disease of the bone in men and women
- Osteoporosis caused by glucocorticoid treatment
Side Effects[edit]
Like all medications, risedronic acid can cause side effects. Common side effects include:
Precautions[edit]
Before taking risedronic acid, patients should inform their healthcare provider if they have any of the following conditions:
- Esophageal problems
- Difficulty swallowing
- Low blood calcium levels
- Kidney disease
- Cannot sit or stand up for at least 30 minutes
Interactions[edit]
Risedronic acid can interact with other medications, including:
Patients should inform their healthcare provider of all the medications they are currently taking.
